Dental Caries Prevention by a Natural Product
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03763578 |
|
Recruitment Status :
Completed
First Posted : December 4, 2018
Last Update Posted : February 8, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Dental Caries | Other: Licorice | Not Applicable |
Research hypothesis (Null hypothesis):
The present clinical trial will be conducted to reject or accept the null hypothesis that using Licorice extract mouth wash in addition to standard preventive measures will not differ from using standard preventive measures alone in preventing incidence of new carious lesions.
PICOTS:
P: Population with high caries risk patients
I: Use of licorice.
I2: Use of chlorhexidine
C: Use of standard preventive measures (tooth brushing, tooth paste, interdental cleaning).
O.1: Primary outcome is incidence of new carious lesions
T: Time for measurement is 12 months
S: A Randomized controlled clinical trial (Parallel study)
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 81 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) |
| Primary Purpose: | Prevention |
| Official Title: | Licorice Versus Standard Preventive Measures for the Prevention of Caries Incidence in Young Egyptian Adults: Randomized Controlled Trial |
| Actual Study Start Date : | September 1, 2020 |
| Actual Primary Completion Date : | December 1, 2020 |
| Actual Study Completion Date : | December 30, 2021 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Licorice
licorice is one of the natural products that is listed by the Food and Drug Administration (FDA) as GRAS (generally regarded as safe) when used as food flavoring and sweetening agent which has an antimicrobial, anti-inflammatory and antiviral activity.
|
Other: Licorice
Natural herbal product
Other Names:
|
|
Active Comparator: Chlorhexidine
The "gold standard" of oral therapeutics is Chlorhexidine due to its prolonged broad- spectrum antimicrobial effect.
|
Other: Licorice
Natural herbal product
Other Names:
|
|
No Intervention: Control Group
Participants in this group will follow only the standard preventive measures which is brushing twice a day after breakfast and before bed time and daily flossing interdentally before bed time. (No Mouthwash is used)
|
- Incidence of new carious lesions [ Time Frame: 12 months ]Appearance of new carious lesions within the study duration
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 25 Years (Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients with high caries risk,
- 18-25 years,
- Males or females,
- Medically free patients,
- Patients approving to participate in the study.
Exclusion Criteria:
- Patients who were on antibiotic therapy or corticosteroid therapy for 30 days before the examination,
- Patients had history of professional cleaning in the last 15 days,
- Patients with exposed pulp,
- Evidence of parafunctional habits,
- Patients with developmental dental anomalies,
- Patients undergoing or will start orthodontic treatment,
- Patients with removable prosthesis,
- Periapical Abscess or Fistula.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03763578
| Egypt | |
| Conservative and Esthetic Dentistry Department-Faculty of Dentistry- Cairo University | |
| Cairo, Choose Any State/Province, Egypt, 002 | |
| Responsible Party: | Sara Mohammed Ahmed Mady, Principal Investigator, Cairo University |
| ClinicalTrials.gov Identifier: | NCT03763578 |
| Other Study ID Numbers: |
18941 |
| First Posted: | December 4, 2018 Key Record Dates |
| Last Update Posted: | February 8, 2022 |
| Last Verified: | February 2022 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
| Product Manufactured in and Exported from the U.S.: | No |
|
Dental Caries Tooth Demineralization Tooth Diseases Stomatognathic Diseases |

